These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2007967)

  • 21. Metrologic approaches to setting acceptance criteria: unacceptable and unusual characteristics.
    Hauck WW; Abernethy DR; Williams RL
    J Pharm Biomed Anal; 2008 Nov; 48(3):1042-5. PubMed ID: 18801635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study concept of traditional Chinese medicine quality standards].
    Chen J; Chen L; An Z; Chang Z; Yuan X; Zhan Y
    Zhong Yao Cai; 2002 Oct; 25(10):748-50. PubMed ID: 15562726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of an association in promoting pharmaceutical quality assurance: transfer of know-how based on the buddy system].
    Ba A; Courcambeck A; Degui H
    Med Trop (Mars); 2006 Dec; 66(6):538-41. PubMed ID: 17286016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDA Points to Consider: Technical Product Lifecycle Management. Pharmaceutical Quality System Effectiveness for Managing Post-approval Changes.
    ; Ramnarine E; Busse U; Colao M; Edwards J; O'Donnell K; Jornitz M; Munk M; Seymour M; Simianu M; Skeens L; Vinther A
    PDA J Pharm Sci Technol; 2017; 71(3):252-258. PubMed ID: 28196929
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cause and measure of short of quality control on Chinese medicine herbs].
    Chen J; Chen L; An Z; Yu X; Zhan Y
    Zhong Yao Cai; 2003 Jan; 26(1):43-6. PubMed ID: 12858774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost management organization: the next step for materiel management.
    Schuweiler RC
    J Healthc Resour Manag; 1997 Jun; 15(5):11-8. PubMed ID: 10168654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical quality: big pharma also at fault.
    Prescrire Int; 2012 Feb; 21(124):54. PubMed ID: 22413728
    [No Abstract]   [Full Text] [Related]  

  • 28. [For the increase of qualification of engineering cadres for the chemical and pharmaceutical industry].
    Blazek J
    Cesk Farm; 1974 Dec; 23(10):397-9. PubMed ID: 4455399
    [No Abstract]   [Full Text] [Related]  

  • 29. [Quality control changes in release controller system].
    Smewing J
    Boll Chim Farm; 2001; 140(3):192-4. PubMed ID: 11486613
    [No Abstract]   [Full Text] [Related]  

  • 30. Emerging Technology as a Key Enabler for Modernizing Pharmaceutical Manufacturing.
    Lee SL; Brorson K
    PDA J Pharm Sci Technol; 2017; 71(2):66-67. PubMed ID: 28396563
    [No Abstract]   [Full Text] [Related]  

  • 31. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Improvement of the process of producing pseudoephedrine hydrochloride].
    Li L; Chen J
    Zhongguo Zhong Yao Za Zhi; 2005 May; 30(10):756-8. PubMed ID: 16078376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral Drug Association response to the FDA compliance policy guide, #7132a.13, entitled, "Parametric release--terminally heat sterilized drug products".
    J Parenter Sci Technol; 1988; 42(4):105. PubMed ID: 3183862
    [No Abstract]   [Full Text] [Related]  

  • 35. Validation, risk-benefit analysis.
    Kieffer RG
    PDA J Pharm Sci Technol; 1995; 49(5):249-52. PubMed ID: 7489200
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA pharmaceutical quality oversight.
    Yu LX; Woodcock J
    Int J Pharm; 2015 Aug; 491(1-2):2-7. PubMed ID: 26027494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of ceftriaxone in Pakistan: reality and resonance.
    Obaid A
    Pak J Pharm Sci; 2009 Apr; 22(2):220-9. PubMed ID: 19339236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the recovery spread in analytical development and routine quality control--based on the ICH quality guideline Q2B.
    Schepers U; El Deeb S; Ermer J; Wätzig H
    J Pharm Biomed Anal; 2007 Jan; 43(2):708-10. PubMed ID: 16904281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Microbiological in-process control in drug manufacture].
    Seyfarth VH
    Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.